These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33651913)

  • 21. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
    Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
    Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
    Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F
    Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
    Robin TP; Breeze RE; Smith DE; Rusthoven CG; Lewis KD; Gonzalez R; Brill A; Saiki R; Stuhr K; Gaspar LE; Karam SD; Raben D; Kavanagh BD; Nath SK; Liu AK
    J Neurooncol; 2018 Oct; 140(1):55-62. PubMed ID: 29909499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma.
    Wang X; Haaland B; Hu-Lieskovan S; Colman H; Holmen SL
    Cancer Rep (Hoboken); 2021 Dec; 4(6):e1419. PubMed ID: 34137219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
    Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
    J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan.
    Wada S; Ogata D; Kashihara T; Okuma K; Eto H; Nakano E; Takahashi A; Namikawa K; Igaki H; Yamazaki N
    Cancer Med; 2023 Dec; 12(24):21933-21943. PubMed ID: 38083908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of systemic therapy in melanoma brain metastases: a narrative review.
    Saleem K; Davar D
    Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.
    Chowdhury IH; Ojerholm E; McMillan MT; Miller D; Kolker JD; Kurtz G; Dorsey JF; Nagda SN; Geiger GA; Brem S; O'Rourke DM; Zager EL; Gangadhar T; Schuchter L; Lee JY; Alonso-Basanta M
    Radiat Oncol; 2015 Dec; 10():248. PubMed ID: 26626714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
    Mandalà M; Lorigan P; Sergi MC; Benannoune N; Serra P; Vitale MG; Giannarelli D; Arance AM; Couselo EM; Neyns B; Tucci M; Guida M; Spagnolo F; Rossi E; Occelli M; Queirolo P; Quaglino P; Depenni R; Merelli B; Placzke J; Di Giacomo AM; Del Vecchio M; Indini A; da Silva IP; Menzies AM; Long GV; Robert C; Rutkowski P; Ascierto PA
    Eur J Cancer; 2024 Mar; 199():113542. PubMed ID: 38266540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in melanoma brain metastases in the era of novel systemic therapies.
    Merola JP; Ocen J; Kumar S; Powell J; Hayhurst C
    Neurooncol Adv; 2020; 2(1):vdaa144. PubMed ID: 33392503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
    Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
    J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world data on melanoma brain metastases and survival outcome.
    Pedersen S; Møller S; Donia M; Persson GF; Svane IM; Ellebaek E
    Melanoma Res; 2022 Jun; 32(3):173-182. PubMed ID: 35256571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Treatment of Melanoma Brain Metastasis.
    Rishi A; Yu HM
    Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis.
    Amaral T; Tampouri I; Eigentler T; Keim U; Klumpp B; Heinrich V; Zips D; Paulsen F; Gepfner-Tuma I; Skardelly M; Tatagiba M; Tabatabai G; Garbe C; Forschner A
    Immunotherapy; 2019 Mar; 11(4):297-309. PubMed ID: 30606066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery.
    Rodenburg RJ; Hanssens PE; Ho VKY; Beerepoot LV
    J Neurooncol; 2018 Jun; 138(2):391-399. PubMed ID: 29470692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
    Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
    J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study.
    Tawbi H; To TM; Bartley K; Sadetsky N; Burton E; Haydu L; McKenna E
    Cancer Med; 2022 Jan; 11(1):139-150. PubMed ID: 34874127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.